Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Hemasphere
|
September 5, 2024
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Kai Hübel, Mark Bower, Igor Aurer, et al.
Blood
|
September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Luca Arcaini, Caroline Besson, Marco Frigeni, et al.
Blood Advances
|
December 8, 2022
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, et al.
Haematologica
|
July 18, 2020
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma
Christian W Thorball, Tiphaine Oudot-Mellakh, Nava Ehsan, et al.
American Journal of Hematology
|
November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Blood
|
January 27, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
Davide Rossi, Valeria Spina, Clara Deambrogi, et al.
Blood
|
October 18, 2021
High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis
P Martijn Kolijn, Fatemeh Saberi Hosnijeh, Florentin Späth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
Davide Rossi, Valeria Spina, Michaela Cerri, et al.
Hematological Oncology
|
July 12, 2025
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma
Juliette Penichoux, Pierre Decazes, Cédric Rossi, et al.
The Oncologist
|
December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli, Marco Frigeni, Laurent Alric, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Hemasphere
|
September 5, 2024
Human immunodeficiency virus-associated Lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Kai Hübel, Mark Bower, Igor Aurer, et al.
Blood
|
September 9, 2016
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Luca Arcaini, Caroline Besson, Marco Frigeni, et al.
Blood Advances
|
December 8, 2022
Salvage therapy with brentuximab-vedotin and bendamustine for patients with R/R PTCL: a retrospective study from the LYSA group
Raphaelle Aubrais, Krimo Bouabdallah, Loic Chartier, et al.
Haematologica
|
July 18, 2020
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma
Christian W Thorball, Tiphaine Oudot-Mellakh, Nava Ehsan, et al.
American Journal of Hematology
|
November 25, 2014
Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study
Jean-Marie Michot, Danielle Canioni, Henda Driss, et al.
Blood
|
January 27, 2011
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
Davide Rossi, Valeria Spina, Clara Deambrogi, et al.
Blood
|
October 18, 2021
High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis
P Martijn Kolijn, Fatemeh Saberi Hosnijeh, Florentin Späth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2009
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome
Davide Rossi, Valeria Spina, Michaela Cerri, et al.
Hematological Oncology
|
July 12, 2025
Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma
Juliette Penichoux, Pierre Decazes, Cédric Rossi, et al.
The Oncologist
|
December 16, 2018
Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas
Michele Merli, Marco Frigeni, Laurent Alric, et al.
Page
of 10